| Score | Risk Level | Action |
|---|---|---|
| 0 | Low Risk | Routine clinical care; re-screen hospital weekly, community monthly, care home monthly |
| 1 | Medium Risk | Observe: document dietary intake for 3 days; if adequate — little concern; if inadequate — set goals, improve/increase intake, monitor weekly (hospital) or monthly (community) |
| 2+ | High Risk | Refer to dietitian; improve / increase nutritional intake; monitor and review care plan weekly (hospital), monthly (community); unless detrimental, aim for nutritional improvement |
- BMI may be falsely elevated if oedema/ascites — adjust interpretation
- Height difficult to measure — use knee height or demi-span formula
- Cognitive impairment may affect weight history reliability — involve carers
- MUST valid in hospital, community, and care home settings
- Reassess after any acute illness episode regardless of previous score
- Dehydration may affect body weight measurements
| Question | Options & Score |
|---|---|
| A. Food intake decline in last 3 months (appetite loss, digestive problems, chewing/swallowing difficulties)? | 0=severe decrease; 1=moderate; 2=no decrease |
| B. Weight loss in last 3 months? | 0=>3 kg; 1=unknown; 2=1–3 kg; 3=no loss |
| C. Mobility? | 0=bed/chair bound; 1=out of bed/chair but no outdoor; 2=goes outdoors |
| D. Psychological stress or acute disease in last 3 months? | 0=yes; 2=no |
| E. Neuropsychological problems? | 0=severe dementia/depression; 1=mild dementia; 2=none |
| F1. BMI (if unable to obtain, use calf circumference F2) | 0=<19; 1=19–21; 2=21–23; 3=≥23 |
Useful when weight/height unreliable. Measure at midpoint of upper non-dominant arm.
| MUAC | Interpretation |
|---|---|
| > 23.5 cm | Adequate — Low malnutrition risk |
| 22–23.5 cm | Borderline — Monitor closely |
| < 22 cm | Malnourished — Nutritional support |
Surrogate marker of muscle mass in elderly. Measure widest part of dominant calf, leg at 90°.
| Calf Circumference | Interpretation |
|---|---|
| ≥ 31 cm | No muscle depletion |
| < 31 cm | Sarcopenia risk — Reduced muscle mass |
- Weight change — overall change in 6 months; change in past 2 weeks
- Dietary intake change — suboptimal diet type, duration of change
- GI symptoms — nausea, vomiting, diarrhoea, anorexia > 2 weeks
- Functional capacity — reduced work capacity, ambulatory, bedridden
- Disease & metabolic stress — primary diagnosis, metabolic demand
- Physical examination — loss of subcutaneous fat, muscle wasting, oedema, ascites
- Appetite changes & meal frequency / portion size
- Chewing difficulties — dentition, denture fit
- Swallowing difficulties — refer for dysphagia screen
- Food allergies, intolerances, religious dietary restrictions
- Cooking ability, finances, food access (especially solitary elders)
- Polypharmacy effect on appetite (opioids, digoxin, metformin)
- Alcohol intake history
- Supplement use — vitamins, herbal, halal-certified
- Cultural food preferences & fasting practices (Ramadan)
- Hydration history — fluid intake per day
Malnutrition is a state in which a deficiency or excess (or imbalance) of energy, protein, and other nutrients causes measurable adverse effects on body composition, function, and clinical outcomes.
| Criterion | Moderate | Severe |
|---|---|---|
| Weight loss (%) | 5–10% in 6 mo; 10–20% in 1 yr | >10% in 6 mo; >20% in 1 yr |
| Low BMI (kg/m²) | <20 if <70 yrs; <22 if ≥70 yrs | <18.5 if <70; <20 if ≥70 |
| Reduced muscle mass | Mild–moderate deficit | Severe deficit |
- Reduced food intake / assimilation (<50% EER >1 week, or any reduction >2 weeks, or chronic GI condition)
- Inflammation / disease burden — acute disease/injury OR chronic disease-related inflammation
| Condition | Definition | Key Feature | Reversible? |
|---|---|---|---|
| PEM Protein-Energy Malnutrition | Deficit in protein and/or energy intake leading to wasting | Low BMI, depleted fat stores, muscle loss, hypoalbuminaemia | Yes — with nutrition support |
| Cachexia | Complex metabolic syndrome assoc. with underlying disease causing muscle loss ± fat loss | Anorexia, inflammation (high CRP), involuntary weight loss >5%, fatigue | Partially — treat underlying disease |
| Sarcopenia | Progressive loss of skeletal muscle mass AND strength/function (EWGSOP2) | Low muscle mass + low grip strength / low gait speed | Partially — resistance exercise + protein |
| Frailty | Clinical syndrome of decreased reserve and resistance to stressors (Fried phenotype) | Exhaustion, unintentional weight loss, weakness, slowness, low activity | Yes — with targeted multi-domain intervention |
| Component | Question | Scoring |
|---|---|---|
| Strength | Difficulty lifting/carrying 4.5 kg? | None=0, Some=1, A lot/unable=2 |
| Assistance walking | Difficulty walking across room? | None=0, Some=1, A lot/unable=2 |
| Rise from chair | Difficulty transferring from chair/bed? | None=0, Some=1, A lot/unable=2 |
| Climb stairs | Difficulty climbing 10 steps? | None=0, Some=1, A lot/unable=2 |
| Falls | Times fallen in last year? | None=0, 1–3 falls=1, ≥4 falls=2 |
- DXA (Dual-energy X-ray absorptiometry) — Gold standard; measures appendicular lean mass (ALM); limited by availability in GCC community settings
- BIA (Bioelectrical Impedance Analysis) — Widely available; portable; affected by hydration status; useful in clinic/ward
- CT / MRI — Most accurate; used mainly for research or incidental findings
- Calf circumference < 31 cm — Simple bedside proxy
- Grip strength (Jamar dynamometer) — Low strength: <27 kg men, <16 kg women (EWGSOP2)
- Gait speed ≤ 0.8 m/s — Indicates severe sarcopenia
Physiological Factors
- Reduced thirst sensation (impaired osmoreceptor function)
- Decreased total body water (45–50% vs 60% in young adults)
- Reduced renal concentrating ability
- Decreased ADH responsiveness
- Polypharmacy — diuretics, laxatives, ACE inhibitors
Assessment Limitations
- Skin turgor — unreliable in elderly due to loss of skin elasticity; test at sternum or forehead instead
- Sunken eyes — less reliable; assess in context
- Urine colour & volume — practical bedside marker (aim 30 ml/hr minimum)
- Serum osmolality — >295 mOsm/kg confirms dehydration
- BUN:Creatinine > 20 — suggests pre-renal dehydration
| Tube Type | Indication | Duration | Key Consideration |
|---|---|---|---|
| NGT Nasogastric | Short-term supplemental feeding; swallowing dysfunction; inadequate oral intake; post-op | < 4–6 weeks | Check position before EVERY feed/medication; X-ray gold standard; pH ≤ 5.5 aspirate acceptable |
| NJT Nasojejunal | Gastroparesis; high aspiration risk; pancreatitis; post-GI surgery | < 4–6 weeks | Requires radiological/endoscopic placement confirmation; post-pyloric position |
| PEG Percutaneous Endoscopic Gastrostomy | Long-term enteral feeding (> 4–6 weeks); neurological dysphagia (stroke, dementia, MND); safe swallowing impossible | > 4–6 weeks | Informed consent; consider goals of care; ethical review in dementia patients |
| PEJ Percutaneous Endoscopic Jejunostomy | Gastric emptying failure; severe GORD with aspiration risk; after oesophageal surgery | Long-term | Specialised insertion; small bowel feeds only; no medication boluses |
| Formula Type | Energy | Protein | Indication | GCC Examples |
|---|---|---|---|---|
| Standard polymeric | 1.0 kcal/ml | ~14–16% of energy | Routine elderly feeding, intact GI function | Ensure, Fresubin Original, Jevity |
| High protein | 1.0–1.5 kcal/ml | ≥ 20% of energy (≥ 1.5 g/kg/day) | Sarcopenia, pressure injury healing, post-surgical, hypercatabolic | Ensure Plus Advance, Fresubin Protein Energy |
| Energy-dense | 1.5–2.0 kcal/ml | Variable | Fluid-restricted (renal/cardiac), low-volume tolerance | TwoCal HN, Fresubin 2 kcal |
| Diabetic formula | 1.0 kcal/ml | Variable | DM2 with hyperglycaemia; lower glycaemic index carbohydrates | Glucerna SR, Diason |
| Renal formula | 2.0 kcal/ml | Low-moderate; electrolyte restricted | CKD not on dialysis (low K, PO4, Na) | Suplena, Renilon, Nepro |
| Semi-elemental / elemental | 1.0–1.3 kcal/ml | Peptides / amino acids | Malabsorption, short bowel syndrome, pancreatitis | Peptamen, Vital 1.5 |
- Start at 20–30 ml/hr for 4–8 hours; monitor tolerance
- Increase by 10–20 ml/hr every 4–8 hours if tolerated
- Target rate usually reached within 24–48 hours
- Monitor gastric residual volume (GRV) every 4 hours; hold if GRV > 500 ml (ASPEN) or per local protocol
- Document bowel sounds, abdominal distension, stool output
- Do not dilute standard formula — increases infection risk without benefit
- Start with 100–150 ml every 4–6 hours for first 24 hours
- Increase to 200–300 ml per bolus if tolerated
- Administer over 20–30 minutes via gravity or syringe
- Maintain 30–45° head-of-bed elevation during and 1 hour after feeding
- Flush tube with 30–50 ml water before and after each feed
- Maximum 400–500 ml per bolus for elderly (risk of aspiration)
- HOB ≥ 30–45° at all times during feed
- Check tube position before feed
- Reduce rate if GRV elevated
- Signs: coughing, desaturation, fever, new CXR changes
- Consider post-pyloric tube if recurrent aspiration
- Exclude infectious cause (CDI) first
- Reduce rate; do not dilute formula
- Sorbitol-containing medications via tube — common culprit
- Consider fibre-containing formula
- Review laxatives; ensure no contamination
- Probiotic consideration (pharmacist review)
- Flush 30–50 ml water every 4–6 hours during continuous feeds
- Flush before/after medications and feeds
- Never mix medications together
- If blocked: warm water flush with gentle pressure; carbonated water second option
- Do not use wire stylet to unblock — perforation risk
- NGT: change every 4 weeks per local protocol
Refeeding syndrome (RFS) is a potentially fatal shift in fluids and electrolytes that occurs in malnourished patients after reintroduction of nutrition (enteral, parenteral, or oral). During starvation, the body adapts by using fat and protein as energy sources. When carbohydrates are reintroduced, insulin surges, driving phosphate, potassium, and magnesium from the extracellular space into cells — causing dangerous drops in serum levels.
- BMI < 16 kg/m²
- Unintentional weight loss > 15% in past 3–6 months
- Little or no nutritional intake for > 10 days
- Low levels of potassium, phosphate, or magnesium before feeding
- BMI < 18.5 kg/m²
- Unintentional weight loss > 10% in past 3–6 months
- Little or no nutritional intake for > 5 days
- History of alcohol excess, or drugs including insulin, chemotherapy, antacids, or diuretics
- Check and correct electrolytes (PO4, K, Mg) BEFORE starting nutrition
- Give Thiamine 200–300 mg IV 30 minutes before commencing feeds
- Start at 10 kcal/kg/day (max 5 kcal/kg/day if BMI < 14 or no intake > 15 days)
- Increase slowly over 4–7 days to full requirement (25–30 kcal/kg/day)
- Do NOT restrict sodium-free water; replace electrolytes aggressively
- Monitor daily weight, fluid balance, urine output
- Continue oral B-complex and multivitamin supplements throughout
| Parameter | Pre-feed Baseline | Days 1–3 | Days 4–7 | After Day 7 |
|---|---|---|---|---|
| Phosphate | Essential | Daily | Daily | Alternate days |
| Potassium | Essential | Daily | Daily | Alternate days |
| Magnesium | Essential | Daily | Daily | Alternate days |
| Sodium | Essential | Daily | Daily | Every 2–3 days |
| Glucose (capillary) | Essential | 4–6 hourly | 6–8 hourly | Daily |
| U&E, LFTs | Essential | — | Twice weekly | Weekly |
| Weight / fluid balance | Daily | Daily | Daily | Daily |
Normal: 0.8–1.5 mmol/L
Mild (0.5–0.8): Oral Phosphate-Sandoz or similar
Moderate (<0.5): IV Phosphate infusion; inform medical team immediately
Normal: 3.5–5.0 mmol/L
Mild (3.0–3.5): Oral KCl or Sando-K
Severe (<3.0): IV KCl via central or large peripheral line; cardiac monitor
Normal: 0.7–1.1 mmol/L
Mild (0.5–0.7): Oral Magnesium glycinate/citrate
Severe (<0.5): IV Magnesium sulphate infusion; monitor DTRs, respiratory rate
| IDDSI Level | Description | Test | Clinical Indication |
|---|---|---|---|
| 0 — Thin | Water, juice, tea; flows freely | Flows through 10 ml syringe in <10 s | Normal swallowing |
| 1 — Slightly Thick | Slightly thicker than water | Slower flow than water | Mild oral phase dysfunction |
| 2 — Mildly Thick | Flows off spoon, drizzles | Flows off tilted fork | Reduced lingual control |
| 3 — Liquidised | Smooth, no lumps, pourable | Drips slowly through fork prongs | Moderate oral dysfunction |
| 4 — Puréed | Smooth, no lumps, holds shape on plate | Sits on fork tines | Severe oral dysfunction; laryngeal penetration risk |
| 5 — Minced & Moist | Small soft lumps, ≤ 4 mm | Passes through fork prongs | Reduced mastication / dentition issues |
| 6 — Soft & Bite-Sized | Soft, ≤ 15 mm pieces, can be mashed with tongue | Forkable, no hard pieces | Mild chewing difficulty |
| 7 — Regular | Normal everyday foods | No restriction | Normal swallowing |
- Check patient is alert, sitting upright at ≥ 60°, able to follow instructions
- Assess oral cavity — secretion management, oral hygiene
- Voice quality assessment — hoarse/wet voice = laryngeal involvement
- Test water swallow: 5 ml teaspoon × 3; observe for cough, voice change, O₂ drop
- If no signs of aspiration: 50–90 ml water swallow challenge (various institutions use modified protocols)
- Document: presence of cough, wet/gurgly voice, O₂ saturation change ≥ 2%
- If any signs: STOP; nil-by-mouth; refer to Speech-Language Therapist (SLT) URGENTLY
- Recurrent aspiration pneumonia despite modified diet
- Silent aspiration suspected clinically
- Need to optimise texture/fluid recommendation objectively
- Pre-surgical planning (oesophageal/laryngeal)
- Unclear bedside findings — requires radiological visualisation
Uses barium contrast; real-time X-ray imaging of swallowing phases. Available in most GCC tertiary hospitals.
- Bedside alternative to VFSS — no radiation
- Useful in ICU or non-ambulatory patients
- Visualises pharyngeal phase, vocal cord function
- Detects residue, penetration, aspiration
- Can use actual food/fluids — more representative of real diet
Performed by SLT or ENT; increasingly available in GCC ENT/rehabilitation units.
| Consider PEG If: | Prefer Comfort Feeding If: |
|---|---|
| Reversible cause of dysphagia (e.g., stroke with recovery potential) | Advanced dementia (FAST stage 7) |
| Short-term bridge to recovery | Patient previously expressed refusal (advance directive) |
| Patient/family-informed consent after full discussion | Family distress from tube feeding outweighs benefit |
| Adequate residual quality of life | Recurrent tube dislodgement / distress with tube |
| Non-dementia primary diagnosis | Aspiration despite PEG feeding (post-pyloric aspiration) |
Islamic law (Fiqh) provides a clear exemption from fasting (saum) for the sick, elderly, and frail who would be harmed by fasting. Scholars permit:
- Complete exemption if fasting poses genuine medical risk
- Fidyah (charitable expiation) as alternative for those permanently unable to fast
- Qada (making up missed fasts) later if patient recovers
- Suhoor (pre-dawn meal): High-protein, complex carbohydrate, high-fibre foods; adequate hydration
- Iftar (break-fast): Start with dates + water; avoid sudden large volume intake
- Assess medication timing with pharmacist — diuretics, antihypertensives, insulin regimes must be adjusted
- Hydration critical — ensure 1.5–2 L fluids between Iftar and Suhoor
- Monitor for hypoglycaemia (diabetics), dehydration, electrolyte disturbance
- Enteral feeding for nasogastric patients: most scholars permit NG feeding as it does not constitute "eating" — but patient/family preference and local religious guidance must be respected
| Food | Key Nutrients | Geriatric Benefit | Nurse's Consideration |
|---|---|---|---|
| Dates (Tamr/Rutab) | Potassium, Mg, fibre, natural sugars (glucose/fructose), B-vitamins, iron | Quick energy, constipation prevention, bone health (Mg, Ca), antioxidants | High GI — caution in DM; excellent for malnourished elderly needing energy |
| Zamzam Water | Calcium, Mg, fluoride, bicarbonate | Hydration; cultural significance during illness and Ramadan | Mineral content variable; generally safe; not a therapeutic substitute for fluids |
| Hummus | Protein, fibre, folate, Fe, Zn, B6, unsaturated fats (tahini) | Protein source for sarcopenia prevention; soft texture suitable for dysphagia level 4–5 | Excellent texture-modified food option; high in phosphorus (monitor in CKD) |
| Lentils (Adas) | Plant protein, Fe, folate, fibre, Zn | Affordable high-protein option; prevents constipation; folate for anaemia prevention | Can be blended to IDDSI level 3–4 for dysphagia; watch for gas/bloating in IBS |
| Olive Oil | Monounsaturated fatty acids, polyphenols, Vitamin E | Anti-inflammatory, cardiovascular protective, improves caloric density in frail elderly | Add to puréed foods to increase energy density; no restriction needed in most elderly |
| Harees / Arisa | Complex carbohydrates, protein (wheat + meat), iron | Traditional soft food — easy to eat; culturally significant in Ramadan | Modified texture naturally suits IDDSI level 4–5; can be protein-enriched |
- Osteoporosis and increased fracture risk (falls prevention)
- Proximal muscle weakness — contributes to sarcopenia and falls
- Immune dysfunction — increased infection susceptibility
- Associations with depression, cognitive decline
- Impaired calcium absorption — secondary hyperparathyroidism
| 25-OH Vitamin D Level | Recommendation |
|---|---|
| > 75 nmol/L (30 ng/ml) | Sufficient — Maintenance 800–1000 IU/day |
| 50–75 nmol/L | Insufficient — 1500–2000 IU/day |
| < 50 nmol/L | Deficient — Loading dose protocol; then 1500–2000 IU/day maintenance; ensure adequate calcium intake (1200 mg/day) |
| < 25 nmol/L (severe) | High-dose loading: 50,000 IU weekly × 8–12 weeks (physician order) |
Dietary Strengths
- High legume intake (dhal, lentils) — protein source
- Turmeric — anti-inflammatory properties
- Yoghurt (dahi) — calcium, probiotics
- Rice and vegetable-based diets — fibre
- Spice use can stimulate appetite in anorexic elderly
Nutritional Risks
- Vegetarian elderly — risk of B12, iron, zinc deficiency
- High refined carbohydrate load — DM2 risk
- Ghee and coconut oil in cooking — saturated fat
- Low calcium intake if dairy-avoidant
- Vitamin D deficiency — same risk as Arab elderly
- Salt-preserved foods — hypertension risk
| Product Category | Potential Haram Ingredient | Action |
|---|---|---|
| Sip feeds / ONS (Oral Nutritional Supplements) | Porcine gelatine capsules; lard-based emulsifiers; alcohol-based flavourings | Request halal certificate from manufacturer; many brands (Ensure, Fortisip) offer halal-certified versions |
| Enteral formulas (NGT/PEG) | Animal-derived enzymes, gelatine | Contact manufacturer directly; document patient/family confirmation |
| Omega-3 capsules | Fish gelatine (permissible for most scholars) vs porcine gelatine | Source fish-gelatine or vegan omega-3; confirm with patient's religious preference |
| Probiotic capsules | Porcine gelatine shell; culture media | Use halal-certified probiotics; sachet or powder forms often preferable |
| IV albumin / immunoglobulin | Derived from human blood — permissible under necessity (darura) | Medical necessity overrides restriction; document discussion |
- Ensure ambient temperature in patient rooms ≤ 24°C (air conditioning); humidity 40–60%
- Offer fluids proactively every 1–2 hours regardless of thirst expression
- Minimum target: 30 ml/kg/day fluid intake (adjust for cardiac/renal status)
- Preferred fluids: cooled water, diluted juice, laban (buttermilk), electrolyte drinks, barley water
- For immobile patients — ensure fluid within reach; use adaptive cups if needed
- Monitor urine output: minimum 0.5 ml/kg/hr; dark concentrated urine = dehydration
- Daily electrolyte monitoring in at-risk elderly during summer
- Skin assessment: dry mucous membranes, furrowed tongue, concentrated urine > colour 5–6 on chart